Back to Dashboard








Thermo Fisher Scientific Inc (TMO)
Real-time intraday values
Market Overview
From:
To:
TMO Intraday
No data available
SymbolTMO
IPO DateMar 17, 1980
CEOMr. Marc N. Casper
Full Time Employees125k
SectorHealthcare
IndustryDiagnostics & Research
CountryUnited States
ExchangeNYSE
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services internationally. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Biopharma Services. The Life Sciences Solutions segment includes reagents, instruments, and consumables for biological and medical research; discovery and production of drugs and vaccines; and diagnosis of infections and diseases. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The Specialty Diagnostics segment offers clinical diagnostics products, such as liquid ready-to-use and lyophilized immunodiagnostic reagent kits, calibrators, controls, protein detection assays, and instruments; immunodiagnostic offerings comprising developing, manufacturing, and marketing of complete blood-test systems for the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; microbiology offerings, such as dehydrated and prepared culture media, collection and transport systems, instrumentation and consumables to detect pathogens in blood, diagnostic and rapid direct specimen tests, quality-control products, and associated products; transplant diagnostics products, including human leukocyte antigen typing and testing for the organ transplant market; and healthcare market channel offerings. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.
Performance
| Period | Return % | Value Change |
|---|---|---|
| 1 Day | -0.40% | -2.70 US$ |
| 5 Days | -2.34% | -16.16 US$ |
| 1 Month | +1.28% | +8.54 US$ |
| 6 Months | +43.46% | +204.13 US$ |
Analyzing Market with AI
Evaluating the last 30 days of history and fundamental metrics of TMO...
Key Statistics
Market Cap
249.14B
P/E Ratio
35.54
Div Yield
0.28%
52W High
$705.79
52W Low
$435.27
Analyst Consensus
ConsensusStrong Buy
Bullish2385.2%
Neutral311.1%
Bearish13.7%
52W Analyst Price Targets
Min Target
$560.00
$560.00
Max Target
$830.00
$830.00
Current$673.84
Avg Target$750.92
Analyst Recommendations
Target Price:$750.92($560.00 - $830.00)
Community Thoughts
Share your analysis and sentiment on TMO
Join the community to share your analysis
Latest News for TMO

Should Illumina Stock Holders Look At Thermo Fisher Instead?
Trefis•Oct 23, 2026, 05:36 PM

Thermo Fisher Scientific (TMO) Benefits on Broad-Based Recovery Across Life-Science Markets
Insider Monkey•Oct 23, 2026, 04:23 PM



Is Abbott Stock About To Rebound?
Trefis•Oct 23, 2026, 01:12 PM
Qiagen agrees to private equity takeover
MedTech Dive•Oct 23, 2026, 01:00 PM

Rothschild & Co Redburn Adjusts Thermo Fisher Scientific PT to $750 From $725
MT Newswires•Oct 22, 2026, 01:13 PM

Global Peptide Synthesis Market Forecast to 2031: Size, Share, Trends, and Growth | GLP-1 Boom Lifts Demand for Peptide Synthesis
GlobeNewswire•Oct 22, 2026, 01:02 PM
RBC Raises Price Target on Thermo Fisher Scientific to $730 From $580, Keeps Sector Perform Rating
MT Newswires•Oct 22, 2026, 11:26 AM